Top compounds associated with response to OR4F3


Feature Type Standardized
Nominal ANOVA
mRNA BRD1812 CTRPv2 pan-cancer AAC 0.059 0.09
mRNA BRD-K29086754 CTRPv2 pan-cancer AAC 0.12 0.09
mRNA NVP-BEZ235 CTRPv2 pan-cancer AAC 0.07 0.09
mRNA bendamustine CTRPv2 pan-cancer AAC -0.062 0.09
mRNA MLN2480 CTRPv2 pan-cancer AAC 0.088 0.09
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.051 0.09
mRNA tivantinib CTRPv2 pan-cancer AAC 0.073 0.1
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.057 0.1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.055 0.1
mRNA cediranib CTRPv2 pan-cancer AAC 0.087 0.1
Download CSV